Fürnrohr, B.G.; Rhodes, B.; Munoz, L.E.; Weiß, K.; Vyse, T.J.; Schett, G.
Osteoclast Differentiation Is Impaired in a Subgroup of SLE Patients and Correlates Inversely with Mycophenolate Mofetil Treatment. Int. J. Mol. Sci. 2015, 16, 18825-18835.
https://doi.org/10.3390/ijms160818825
AMA Style
Fürnrohr BG, Rhodes B, Munoz LE, Weiß K, Vyse TJ, Schett G.
Osteoclast Differentiation Is Impaired in a Subgroup of SLE Patients and Correlates Inversely with Mycophenolate Mofetil Treatment. International Journal of Molecular Sciences. 2015; 16(8):18825-18835.
https://doi.org/10.3390/ijms160818825
Chicago/Turabian Style
Fürnrohr, Barbara G., Benjamin Rhodes, Luis E. Munoz, Katrin Weiß, Tim J. Vyse, and Georg Schett.
2015. "Osteoclast Differentiation Is Impaired in a Subgroup of SLE Patients and Correlates Inversely with Mycophenolate Mofetil Treatment" International Journal of Molecular Sciences 16, no. 8: 18825-18835.
https://doi.org/10.3390/ijms160818825
APA Style
Fürnrohr, B. G., Rhodes, B., Munoz, L. E., Weiß, K., Vyse, T. J., & Schett, G.
(2015). Osteoclast Differentiation Is Impaired in a Subgroup of SLE Patients and Correlates Inversely with Mycophenolate Mofetil Treatment. International Journal of Molecular Sciences, 16(8), 18825-18835.
https://doi.org/10.3390/ijms160818825